Related Experiment Video
Updated: Jul 1, 2025
12:12
Identification of Hemolytic and Phospholipase Activity in Crude Extracts from Sea Anemones by Straightforward Bioassays
Published on: March 29, 2022
2.8K
Ranunculin, Protoanemonin, and Anemonin: Pharmacological and Chemical Perspectives.
Betelhem Sirak1, Misgana Aragaw2, Solomon Tadesse3
1Department of Pharmacy, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.
Current Medicinal Chemistry
|March 1, 2024
Summary
Anemonin, derived from Ranunculaceae plants, shows potent anti-inflammatory and anti-infective properties. This compound holds promise for treating conditions like arthritis and ulcerative colitis, making it a key molecule for bioassays.
Area of Science:
- Phytochemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Ranunculin is a glucoside found in Ranunculaceae plants, acting as a chemotaxonomic marker.
- Damage to these plants activates β-glucosidase, converting ranunculin to protoanemonin, which then forms anemonin.
Purpose of the Study:
- To review the chemistry and biological properties of anemonin and its precursors.
- To explore the potential of anemonin in various biological assays and therapeutic applications.
Main Methods:
- Extraction and isolation of anemonin from plant sources.
- Chemical synthesis of anemonin.
- In vitro and in vivo bioactivity investigations.
- Pharmacokinetic studies.
Main Results:
- Anemonin exhibits significant anti-inflammatory, anti-infective, and anti-oxidant effects.
- Anemonin demonstrates therapeutic potential for arthritis, cerebral ischemia, and ulcerative colitis.
- Anemonin effectively inhibits nitric oxide synthesis and counteracts lipopolysaccharide-induced inflammation.
Conclusions:
- Anemonin is a stable and promising molecule for biological assays, unlike its unstable precursors.
- Anemonin's diverse biological activities suggest its potential as a therapeutic agent for various inflammatory and infectious diseases.
Related Concept Videos
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
512
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
512
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
01:26Physical Properties of Amines
3.1K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.1K
01:24Cholinergic Antagonists: Pharmacokinetics
439
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
439
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
958
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
958
01:25Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K